RT Conference Proceedings
T1 RECOMMENDATIONS FOR NURSES IN THE MANAGEMENT OF RA PATIENTS ON TREATMENT WITH JAKINIBS
A1 Martin-Martin, J. M.
A1 Garcia-Diaz, S.
A1 Molina, A.
A1 Dominguez, C.
A1 Carmona, L.
A1 Cano-Garcia, L.
K1 Therapeutics
K1 Patients
K1 Nurses
AB Background: The number of new treatments available in rheumatology continues to increase. Kinase inhibitors, or jakinibs, pose an added challenge due to their variety and because they are oral. The most important role of the rheumatology nurse is patient education, especially on how to take the medication. The better the nurse understands the drugs, the better their practical recommendations and decisions will be, and the better they will be able to respond to the patient. Guidelines or recommendations for inflammatory diseases do not usually include key practical details for nurses. It is our understanding that these points, which will subsequently determine adherence and safety, should be specially addressed in a specific document for nurses.
PB Bmj publishing group
SN 0003-4967
YR 2022
FD 2022-06-01
LK http://hdl.handle.net/10668/20125
UL http://hdl.handle.net/10668/20125
LA en
NO Martín, J. M. M., García-Díaz, S., Molina, A., Dominguez, C., Carmona, L., & Garcia, L. C. (2022). OP0213-HPR RECOMMENDATIONS FOR NURSES IN THE MANAGEMENT OF RA PATIENTS ON TREATMENT WITH JAKINIBS. Annals Of The Rheumatic Diseases, 81(Suppl 1), 139.2-139
DS RISalud
RD Apr 9, 2025